{"organizations": [], "uuid": "ee2a4288090d2c3638c8fe2c6bc43db860bb80d8", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180221.html", "section_title": "Archive News &amp; Video for Wednesday, 21 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/health-purdue/montana-seeks-to-block-purdue-pharma-from-promoting-opioids-idUSL2N1QB2EU", "country": "US", "domain_rank": 408, "title": "Montana seeks to block Purdue Pharma from promoting opioids", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.077, "site_type": "news", "published": "2018-02-22T07:47:00.000+02:00", "replies_count": 0, "uuid": "ee2a4288090d2c3638c8fe2c6bc43db860bb80d8"}, "author": "Nate Raymond", "url": "https://www.reuters.com/article/health-purdue/montana-seeks-to-block-purdue-pharma-from-promoting-opioids-idUSL2N1QB2EU", "ord_in_thread": 0, "title": "Montana seeks to block Purdue Pharma from promoting opioids", "locations": [], "entities": {"persons": [{"name": "tim fox", "sentiment": "none"}], "locations": [{"name": "montana", "sentiment": "none"}], "organizations": [{"name": "purdue pharma", "sentiment": "negative"}, {"name": "westlaw", "sentiment": "none"}, {"name": "purdue pharma lp", "sentiment": "none"}, {"name": "purdue", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Montanaâ€™s attorney general on Wednesday announced he was seeking a court order that would block OxyContin maker Purdue Pharma LP from promoting opioids while the state pursues a lawsuit against the drugmaker.\nThe motion by Montana Attorney General Tim Fox was the first of its kind by a state amid a wave of lawsuits against Purdue and other companies contending they deceptively marketed opioids and contributed to a national drug abuse epidemic.\nTo read the full story on Westlaw Practitioner Insights, click here: bit.ly/2FnF1la\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html", "http://bit.ly/2FnF1la"], "published": "2018-02-22T07:47:00.000+02:00", "crawled": "2018-02-22T17:54:12.016+02:00", "highlightTitle": ""}